Gilgamesh Pharma

Gilgamesh is a clinical-stage biotech whose vision is to reshape how mental illnesses are treated by shifting away from symptom management to a focus on rapid-acting and durable therapies targeting the fundamental drivers of disease. We do this by designing best-in-class new chemical entities (NCEs) acting through proven mechanisms, which are optimized for safety, efficacy, and patient access[1][2]

Visit website Suggest an update

2019 Founded

Overview

Gilgamesh Pharma is a clinical-stage biotech company operating in the New York AI scene [1]. Founded in 2019, the company focuses on reshaping treatment approaches for mental illnesses [2]. Rather than emphasizing symptom management, Gilgamesh's vision centers on developing rapid-acting and durable therapies that target the fundamental drivers of disease [2]. The company designs new chemical entities acting through proven mechanisms, with optimization for safety, efficacy, and patient access [2]. Gilgamesh operates in the pharmaceutical manufacturing industry [3] and maintains a workforce of approximately 35 employees [3].

Business address: 113 University Pl, New York, New York, 10003. [6]

Growth & traction

LinkedIn lists 35 people working at Gilgamesh Pharma. [4]

Something wrong or missing? Send an update. Fixed within 24 hours.